紫云英苷抗肿瘤作用相关信号通路的研究进展

doi:10.11904/j.issn.1002-3070.2024.01.010

实用肿瘤学杂志 ›› 2024, Vol. 38 ›› Issue (1): 62-66.doi: 10.11904/j.issn.1002-3070.2024.01.010

紫云英苷抗肿瘤作用相关信号通路的研究进展

肖鼎^1,2, 白俊丞² 综述, 张彬² 审校

肖鼎,男,(1988-),硕士,主治医师,从事胸部肿瘤临床与基础的研究。

收稿日期:2023-10-31 修回日期:2024-01-08 出版日期:2024-02-28 发布日期:2024-06-21
通讯作者: 张彬,E-mail:Binzhang7778@163.com
作者简介:1.内蒙古民族大学临床医学院(通辽 028000);2.内蒙古民族大学附属医院心脏、血管外科
基金资助:
内蒙古自治区直属高校项目(编号:GXKY22098)

Research progress of signal pathways related to the anti-tumor effect of Astragalin

XIAO Ding^1,2, BAI Juncheng², ZHANG Bin²

1. Clinical Medical College,Inner Mongolia MinZu University,Tongliao 028000,China;
2. Affiliated Hospital of Inner Mongolia MinZu University Cardiovascular surgery

Received:2023-10-31 Revised:2024-01-08 Online:2024-02-28 Published:2024-06-21

摘要/Abstract

摘要： 紫云英苷是一种天然的类黄酮,以抗肿瘤等多样化的药理应用而闻名。研究发现紫云英苷具有巨大的抗肿瘤潜力,通过调节PI3K/Akt信号通路、MAPKs信号通路、JAK/STAT信号通路、NF-κB信号通路、Notch1通路、microRNA的表达、肿瘤侵袭和转移等诱导肿瘤细胞凋亡,抑制肿瘤的增殖、侵袭和迁移。本文综述了近年来紫云英苷有关抗肿瘤信号通路的文献报道,分析并总结了每一条通路诱导肿瘤细胞凋亡的可能机制,以期为紫云英苷在抗肿瘤信号通路的开发和利用提供实验和理论依据。

关键词: 紫云英苷, 抗肿瘤, 信号通路

Abstract: Astragalin is a natural flavonoid,which is known for its diverse pharmacological applications such as anti-tumor.The many studies have found that Astragalin has great anti-tumor potential by regulating PI3K/Akt signal pathway,MAPKs signal pathway,JAK/STAT signal pathway,NF-κ B signal pathway,Notch1 pathway,microRNA expression,tumor invasion and metastasis.This article reviews the literature reports on anti-tumor signal pathway of Astragalin in recent years,analyzes and summarizes the possible mechanisms by which each pathway induces tumor cell apoptosis,in order to provide experimental and theoretical basis for the development and utilization of Astragalin in anti-tumor signal pathways.

Key words: Astragalin, Anti-tumor, Signaling pathway

中图分类号:

R285

肖鼎, 白俊丞, 张彬. 紫云英苷抗肿瘤作用相关信号通路的研究进展[J]. 实用肿瘤学杂志, 2024, 38(1): 62-66.

XIAO Ding, BAI Juncheng, ZHANG Bin. Research progress of signal pathways related to the anti-tumor effect of Astragalin[J]. Journal of Practical Oncology, 2024, 38(1): 62-66.

参考文献

1 陈世春,徐永祥,韩伟超,等.紫云英苷的药理特性及其作用机制研究进展[J].中华中医药学刊,2022,40(11):118-123.
2 Riaz A,Rasul A,Hussain G,et al.Astragalin:a bioactive phytochemical with potential therapeutic activities[J].Adv Pharmacol Sci,2018,2018:9794625:1-15.
3 Alzahrani AS.PI3K/Akt/mTOR inhibitors in cancer:At the bench and bedside[J].Semin Cancer Biol,2019,59:125-132.
4 Wang Z,Lv J,Li X,et al.The flavonoid Astragalin shows anti-tumor activity and inhibits PI3K/AKT signaling in gastric cancer[J].Chem Biol Drug Des,2021,98(5):779-786.
5 褚智恒,何施燕,王瑜,等.紫云英苷对未分化胃癌细胞凋亡的影响[J].中国应用生理学杂志,2022,38(5):520-524.
6 Chen M,Cai F,Zha D,et al.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-κB pathway[J].Oncotarget,2017,8(16):26941-26958.
7 Tian S,Wei Y,Hu H,et al.Mixed computational-experimental study to reveal the anti-metastasis and anti-angiogenesis effects of Astragalin in human breast cancer[J].Comput Biol Med,2022,150:106131.
8 Wagner EF,Nebreda AR.Signal integration by JNK and p38 MAPK pathways in cancer development[J].Nat Rev Cancer,2009,9(8):537-549.
9 Jia XB,Zhang Q,Xu L,et al.Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway[J].Biol Res,2021,54(1):7.
10 Kim H,Hwang B,Cho S,et al.The ethanol extract of Cyperus exaltatus var.iwasakii exhibits cell cycle dysregulation,ERK1/2/p38 MAPK/AKT phosphorylation,and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo[J].Phytomedicine,2023,114:154794.
11 Jintana T,Naoto Y,Perayot P,et al.Anti-proliferative effect of Moringa oleifera Lam(Moringaceae)leaf extract on human colon cancer HCT116 cell line[J].Tropical Journal of Pharmaceutical Research,2017,16(2):371-378.
12 Burmistrova O,Quintana J,Díaz JG,et al.Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway[J].Cancer Lett,2011,309(1):71-77.
13 Hu X,Li J,Fu M,et al.The JAK/STAT signaling pathway:from bench to clinic[J].Signal Transduct Target Ther,2021,6(1):402.
14 Xu G,Yu B,Wang R,et al.Astragalin flavonoid inhibits proliferation in human lung carcinoma cells mediated via induction of caspase-dependent intrinsic pathway,ROS production,cell migration and invasion inhibition and targeting JAK/STAT signalling pathway[J].Cell Mol Biol(Noisy-le-grand),2021,67(2):44-49.
15 王瑜,朱明了,何施燕,等.紫云英苷诱导DLBCL细胞系OCI-LY8凋亡[J].中国病理生理杂志,2021,37(5):885-890.
16 Taniguchi K,Karin M.NF-κB,inflammation,immunity and cancer:coming of age[J].Nat Rev Immunol,2018,18(5):309-324.
17 Radziejewska I,Supruniuk K,Tomczyk M,et al.p-Coumaric acid,kaempferol,astragalin and Tiliroside Influence the expression of glycoforms in ags agstric cancer cells[J].Int J Mol Sci,2022,23(15):8602.
18 Sokolova O,Naumann M.NF-κB signaling in gastric cancer[J].Toxins(Basel),2017,28:9(4):119.
19 Yang M,Li WY,Xie J,et al.Astragalin inhibits the proliferation and migration of human colon cancer HCT116 cells by regulating the NF-κB signaling pathway[J].Front Pharmacol,2021,12:639256.
20 Li J,Shen J,Zhao Y,et al.Role of miR-181a-5p in cancer(Review)[J].Int J Oncol,2023,63(4):108.
21 Zhu L,Zhu L,Chen J,et al.Astragalin induced selective kidney cancer cell death and these effects are mediated via mitochondrial mediated cell apoptosis,cell cycle arrest,and modulation of key tumor-suppressive miRNAs[J].J BUON,2019,24(3):1245-1251.
22 Li W,Hao J,Zhang L,et al.Astragalin reduces hexokinase 2 through increasing mir-125b to inhibit the proliferation of hepatocellular carcinoma cells in vitro and in vivo[J].J Agric Food Chem,2017,65(29):5961-5972.
23 Roy M,Pear WS,Aster JC.The multifaceted role of Notch in cancer[J].Curr Opin Genet Dev,2007,17(1):52-59.
24 Huang WH,Liao WR,Sun RX.Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1[J].Int J Mol Med,2016,38(2):551-557.
25 Lyu Y,Xiao Q,Yin L,et al.Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis[J].Signal Transduct Target Ther,2019,4:26.
26 宋玲,付琼.紫云英苷通过上调PHD2抑制缺氧诱导的卵巢癌细胞增殖和侵袭[J].实用肿瘤学杂志,2019,33(5):407-414.
27 宋玲,付琼.紫云英苷通过抑制HIF-1α诱导的糖酵解途径发挥抗卵巢肿细胞作用的研究[J].实用肿瘤学杂志,2018,32(6):503-509.
28 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.

[1]	郑鹏飞, 董良鹏, 高延鑫, 张一夫, 秦双. 白细胞介素-38对乳腺癌患者CD8⁺T淋巴细胞功能的影响[J]. 实用肿瘤学杂志, 2024, 38(1): 30-36.
[2]	薛羽婷, 毛雄辉, 孙冀, 苑振楠. 长链非编码RNA LINC-PINT通过Hippo/YAP信号通路在缺氧诱导的头颈部鳞状细胞癌药物敏感性中的作用研究[J]. 实用肿瘤学杂志, 2023, 37(6): 466-471.
[3]	赵世博, 陈永峰, 黎惠怡, 符爱珍. Agrin参与恶性肿瘤发生发展的研究现状[J]. 实用肿瘤学杂志, 2023, 37(6): 507-512.
[4]	庄忆君, 孙禹琪, 杨微. β-榄香烯调控PI3K/Akt/mTOR信号通路对子宫内膜癌Ishikawa细胞增殖、迁移、侵袭及凋亡的影响[J]. 实用肿瘤学杂志, 2023, 37(5): 395-402.
[5]	王艳芳, 张朕豪, 王化, 郤连永, 董菲, 景红梅. 多发性骨髓瘤环状RNA的差异表达情况及生物学功能研究[J]. 实用肿瘤学杂志, 2023, 37(4): 313-319.
[6]	刘欣欣, 马西元, 缪美琪, 王语晴, 陈晶. IL-6及其受体在乳腺癌治疗中的作用研究进展[J]. 实用肿瘤学杂志, 2023, 37(2): 149-154.
[7]	明成, 武云. Wnt信号通路及其抑制剂在胃癌中的研究进展[J]. 实用肿瘤学杂志, 2023, 37(2): 190-194.
[8]	蔡圻锐, 于晓兰, 刘家仁. 香叶醇抗肿瘤活性及其他生物学作用的研究进展[J]. 实用肿瘤学杂志, 2023, 37(1): 58-62.
[9]	陈函, 罗晓勇, 李朝萍, 郭彩茹, 鞠文翠, 翟秧秧, 师鑫鹏. lncRNA CASC2对结直肠癌细胞功能及血管生成的影响[J]. 实用肿瘤学杂志, 2022, 36(2): 111-118.
[10]	孟鑫, 鲁金月, 张爱琳, 何录文. 藤梨根抗肿瘤药效物质和药理活性研究进展[J]. 实用肿瘤学杂志, 2022, 36(1): 69-73.
[11]	李娜, 邓茜, 蒋建军. NF-κB信号通路在恶性肿瘤化疗耐药中的作用[J]. 实用肿瘤学杂志, 2021, 35(6): 580-584.
[12]	尹琦, 胡彦建, 崔普泽, 胡彦华. Notch信号通路调控肿瘤细胞凋亡机制研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 165-169.
[13]	鲁雪梅, 李云涛, 安锦慧, 季国忠. 溶血磷脂酸在结直肠癌发生发展中的机制研究[J]. 实用肿瘤学杂志, 2020, 34(3): 276-281.
[14]	马悦, 马志刚, 于杨, 郑桐森, 张艳桥, 张纯慧. 新型冠状病毒肺炎疫情期间抗肿瘤药物临床试验的管理[J]. 实用肿瘤学杂志, 2020, 34(2): 103-106.
[15]	王飞, 朱贲贲. 丙泊酚经HIF-1α信号通路对头颈鳞状细胞癌SCC-74细胞增殖、凋亡与侵袭的影响[J]. 实用肿瘤学杂志, 2020, 34(2): 120-125.

紫云英苷抗肿瘤作用相关信号通路的研究进展

Research progress of signal pathways related to the anti-tumor effect of Astragalin

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价